Golumbeski George Insider Trading

Get the latest insider transactions of Golumbeski George. Golumbeski George is Director in ENANTA PHARMACEUTICALS INC ($ENTA) and Director in Corbus Pharmaceuticals Holdings, Inc. ($CRBP) and in Sage Therapeutics, Inc. ($SAGE) and Director in Shattuck Labs, Inc. ($STTK). Discover the current value of Golumbeski George shares.

Address: 128 SIDNEY STREET CAMBRIDGE 02199MA

Golumbeski George is Insider in these Companies

TickerCompany NameCurrent and Previous PositionsTotal SharesCurrent Value ($)
ENTAENANTA PHARMACEUTICALS INCDirector9,280298,816.00
SAGESage Therapeutics, Inc.00.00
CRBPCorbus Pharmaceuticals Holdings, Inc.Director00.00
STTKShattuck Labs, Inc.Director0

Insider Trading Transactions of Golumbeski George

DateTickerCompanyOwnerRelationship Transaction Cost ($) Shares Transaction Value ($) Total Shares
Jan 06 2021SAGESage Therapeutics, Inc.Golumbeski GeorgeOption Exercise84.4183270,229832
Dec 28 2020STTKShattuck Labs, Inc.Golumbeski GeorgeDirectorOption Exercise53.021,28668,1841,286
Jul 08 2020CRBPCorbus Pharmaceuticals Ho ...Golumbeski GeorgeDirectorOption Exercise7.9181,000640,71081,000
Jun 11 2020SAGESage Therapeutics, Inc.Golumbeski GeorgeOption Exercise36.4710,000364,70010,000
Feb 28 2020ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorOption Exercise51.0410,000510,40010,000
Jan 07 2020SAGESage Therapeutics, Inc.Golumbeski GeorgeOption Exercise73.5397671,765976
Jun 06 2019SAGESage Therapeutics, Inc.Golumbeski GeorgeOption Exercise177.4110,0001,774,10010,000
Mar 06 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorBuy36.619,280339,7419,280
Mar 06 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorSell103.659,280961,8970
Mar 06 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorOption Exercise36.619,280339,7410
Mar 06 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorBuy36.619,280339,7419,280
Mar 06 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorSell103.659,280961,8970
Mar 06 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorOption Exercise36.619,280339,7410
Mar 01 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorOption Exercise102.545,000512,7005,000
Feb 13 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorBuy25.582,27258,1182,272
Feb 13 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorSell90.032,272204,5520
Feb 13 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorBuy25.583,72895,3623,728
Feb 13 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorBuy29.027,500217,65011,228
Feb 13 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorSell90.0711,2281,011,3010
Feb 13 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorOption Exercise25.582,27258,1183,728
Feb 13 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorOption Exercise25.583,72895,3620
Feb 13 2019ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorOption Exercise29.027,500217,6500
Jan 24 2019SAGESage Therapeutics, Inc.Golumbeski GeorgeOption Exercise137.2920,0002,745,80020,000
Mar 05 2018ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorOption Exercise78.627,500589,6507,500
Feb 21 2017ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorOption Exercise29.027,500217,6507,500
Feb 12 2016ENTAENANTA PHARMACEUTICALS IN ...Golumbeski GeorgeDirectorOption Exercise25.586,000153,4806,000